Cancer Research UK appoints new Trustee
Cancer Research UK today announced the appointment of Professor Alexander Eggermont MD PhD as a Trustee.
Professor Eggermont is Director General of the Institut Gustave Roussy Cancer Center in Paris, one of Europe’s leading cancer research institutes. He is Professor of Oncology at the Paris-Sud University and also Professor of Surgical Oncology and Endowed Professor of International Networking in Cancer Research at the Erasmus University Medical Centre, Rotterdam. He holds the Joseph Maisin Chair in Oncology at the Catholic University of Louvain and was conferred the honour of Chevalier of the Legion d’Honneur in January 2015.
Professor Eggermont obtained his PhD in tumour immunology at the Erasmus University, Rotterdam in 1987. His clinical specialties include immunotherapy, melanoma, sarcoma and regional therapy techniques as well as general drug development. His basic research experience is in tumour immunology, advanced in vivo imaging models and tumour pathophysiology. He is a Fellow of the Surgery Branch of the National Cancer Institute, USA.
Professor Eggermont is President of the European Academy of Cancer Sciences and President of Cancer Core Europe. He chairs the Adjuvant Therapy Committee European Organisation for the Research and Treatment of Cancer (EORTC) Melanoma Group and is a past chair of the EORTC Melanoma Group.
Michael Pragnell, Chairman of Cancer Research UK, said: “Alexander Eggermont is a renowned oncologist who brings extensive international experience to the Charity. I am delighted to welcome him to our governing Council and I much look forward to working with him.”
All Trustee roles at Cancer Research UK are unremunerated.
For media enquiries contact the Cancer Research UK press office on 020 3469 8300 or out of hours on 07050 264 059.